Julie Rubinstein Adaptive Biotechnologies Corp (ADPT) insider trading activity

Julie Rubinstein is President of Adaptive Biotechnologies Corp. Currently has a direct ownership of 472,754 shares of ADPT, which is worth approximately $2.09 Million. The most recent transaction as insider was on Feb 16, 2021, when has been sold 15,000 shares (Common Stock) at a price of $65.04 per share, resulting in proceeds of $975,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 473K

0% 3M change

40.36% 12M change

Total Value Held $2.09 Million

JULIE RUBINSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 16 2021	SELL Open market or private sale	$975,600 $65.04 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 12 2021	SELL Open market or private sale	$988,050 $65.87 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 11 2021	SELL Open market or private sale	$950,850 $63.39 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 11 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 10 2021	SELL Open market or private sale	$952,500 $63.5 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 10 2021	BUY Exercise of conversion of derivative security	$98,250 $6.55 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 09 2021	SELL Open market or private sale	$936,300 $62.42 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 09 2021	BUY Exercise of conversion of derivative security	$96,600 $6.44 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 08 2021	SELL Open market or private sale	$933,000 $62.2 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$94,800 $6.32 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 05 2021	SELL Open market or private sale	$898,200 $59.88 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$94,800 $6.32 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 04 2021	SELL Open market or private sale	$885,150 $59.01 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 04 2021	BUY Exercise of conversion of derivative security	$94,800 $6.32 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 03 2021	SELL Open market or private sale	$901,800 $60.12 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$94,800 $6.32 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 02 2021	SELL Open market or private sale	$888,900 $59.26 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$94,800 $6.32 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 01 2021	SELL Open market or private sale	$835,200 $55.68 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$94,800 $6.32 p/Share	15,000 Added 50.0%	15,000 Common Stock
Jan 29 2021	SELL Open market or private sale	$850,500 $56.7 p/Share	15,000 Reduced 100.0%	0 Common Stock
Jan 29 2021	BUY Exercise of conversion of derivative security	$94,800 $6.32 p/Share	15,000 Added 50.0%	15,000 Common Stock
Jan 28 2021	SELL Open market or private sale	$838,050 $55.87 p/Share	15,000 Reduced 100.0%	0 Common Stock

Julie Rubinstein

President

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account